Dabigatran etexilate in people with atrial fibrillation

被引：3
|
作者：
Raju, Nina C. [1 ]
Hankey, Graeme J. [2 ]
机构：
[1] McMaster Univ, Hamilton Gen Hosp, Thrombosis Unit, Hamilton, ON L8L 2X2, Canada
[2] Univ Western Australia, Royal Perth Hosp, Dept Neurol, Perth, WA 6000, Australia
来源：
BRITISH MEDICAL JOURNAL | 2010年 / 341卷
关键词：
STROKE; ANTICOAGULATION; CLOPIDOGREL; ASPIRIN;
D O I：
10.1136/bmj.c3784
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2017, 77 : 331 - 344
  • [2] Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2017, 77 (03) : 331 - 344
  • [3] Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation
    Scott, Katie A.
    Amirehsani, Karen A.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2015, 27 (04) : 190 - 196
  • [4] Economic Evaluation of Dabigatran Etexilate in the Management of Atrial Fibrillation in Greece
    Andrikopoulos, George K.
    Fragoulakis, Vasilis
    Maniadakis, Nikos
    HELLENIC JOURNAL OF CARDIOLOGY, 2013, 54 (04) : 289 - 300
  • [5] Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
    Huber, K.
    Connolly, S. J.
    Kher, A.
    Christory, F.
    Dan, G. -A.
    Hatala, R.
    Kiss, R. G.
    Meier, B.
    Merkely, B.
    Pieske, B.
    Potpara, T.
    Stepinska, J.
    Klun, N. Vene
    Vinereanu, D.
    Widimsky, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (06) : 516 - 526
  • [6] Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
    Yamaji, Hirosuke
    Murakami, Takashi
    Hina, Kazuyoshi
    Higashiya, Shunichi
    Kawamura, Hiroshi
    Murakami, Masaaki
    Kamikawa, Shigeshi
    Hirohata, Satoshi
    Kusachi, Shozo
    CLINICAL DRUG INVESTIGATION, 2013, 33 (06) : 409 - 418
  • [7] Practical application of dabigatran etexilate for stroke prevention in patients with atrial fibrillation
    Kosmacheva, E. D.
    Kanorskiy, S. G.
    Kastanayan, A. A.
    Haylo, N. V.
    Goltyapin, D. B.
    Lipnitskaya, E. A.
    Statsenko, M. E.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (05) : 551 - 556
  • [8] Pharmacoeconomic Analysis of Dabigatran Etexilate Effectiveness in Patients With Nonvalvular Atrial Fibrillation
    Belousov, Yu. B.
    Mareev, V. Yu.
    Yavelov, I. S.
    Belousov, D. YU.
    Afanasieva, E. V.
    KARDIOLOGIYA, 2012, 52 (01) : 44 - 51
  • [9] The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients
    Ellis, Christopher R.
    Kaiser, Daniel W.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 341 - 352
  • [10] Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
    Hirosuke Yamaji
    Takashi Murakami
    Kazuyoshi Hina
    Shunichi Higashiya
    Hiroshi Kawamura
    Masaaki Murakami
    Shigeshi Kamikawa
    Satoshi Hirohata
    Shozo Kusachi
    Clinical Drug Investigation, 2013, 33 : 409 - 418
12345